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ABSTRACT
Introduction: Hydrogen peroxide is an important intermediate ofendogenous free radical
activity which could lead to the generation of more potent free radicals that cause
macromolecular damage. An imbalance between the excessive generation of pro-oxidant
(free radicals) and insufficient antioxidant defence leads to oxidative stress and this event
is marked in end stage renal disease (ESRD) patients. The objective of this study is to
assess the correlation between serum hydrogen peroxide level and oxidative damage indices
as well as several biochemical markers in ESRD patients. Methods: Fasting blood samples
were collected from patients (n=106) attending the University Malaya Medical Centre,
Kuala Lumpur. The control subjects mainly comprised healthy blood donors with no
known clinical/biochemical abnormality. The serum and plasrna were separated and the
levels of hydrogen peroxide, oxidative damage indices (pentosidine, advanced oxidation
protein products, malonaldehyde) and biochemical parameters (albumin, creatinine, fenitin,
triglyceride, low density lipoproteins and total cholesterol) were estimated according to
established rnethods. Results: Levels of hydrogen peroxide and the oxidative damage
indices were significantly higher in the patients compared to healthy subjects. A strong
positive correlation was present between hydrogen peroxide and the oxidative indices
(r>0.80, p<0.001). Hydrogen peroxide was posit ively (weak) associated with the
biochemical parameters except for albumin levels which showed a negative correlation with
hydrogen peroxide levels in these patients (r:  -0.40, p< 0.01). Conclusion: Serum
hydrogen peroxide strongly correlates with oxidative damage indices and could serve as an
additional marker of oxidative stress in end stage renal disease.
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INTRODUCTION
An imbalance between the excessive generation of pro-oxidant and insufficient antioxidant
defence mechanism leads to oxidative stress.[] In several disease conditions l ike
hyperglycemia and uremia, the increase in oxidative stress is partly due to reactive oxygen
species (ROS) and this may lead to more severe complications such as atherosclerosis and
hypertension which increase the mortality and morbidity rate in these patients.tzl
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Physiologically, a small amount of ROS is required in signaling pathways to activate the
cells. Over production of ROS can cause significant cellular damage through the alteration
of protein structure of the signal molecules and thus destroys its function. trl
Increased ROS-mediated oxidative stress has been observed in end stage renal disease
(ESRD) patients and it results in the oxidation of important macro-molecules such as
carbohydrates, proteins, lipids and nucleic acids.t3l The direct measurement of ROS in vivo
is extremely difficult as these molecules are produced in minute quantities and are highly
reactive. However, to elucidate the role of ROS in contributing to many pathological states
including uremia, numerous stable end products of oxidant stress have been identified and
these include malonaldehyde (MDA), pentosidine and advanced oxidation protein products
(AOPP) for the oxidation products of lipids, carbohydrates and protein respectively. These
biomarkers of oxidative stress have been reported to be elevated in ESRD patients.tzl
Hydrogen Peroxide (HrOr) is one of the ROS which serves as a key intermediate for a
number ofoxidative stress conditions including atherosclerosis and diabetic vasculopathy.
It has a very short half life in the circulation and reacts with the hemeprotein, ascorbate and
protein-thiol groups. The in vlvo plasma HrO, could diffuse into the erythrocyte, white
blood cells, endothelial cells and platelet for metabolism. Although HrO, is involved in the
regulation of renal function and can act as an antibacterial agent in the urine, it is toxic to
cells when in excess. Its levels are minimised by the action of antioxidant defence mechanisms
especially catalase and glutathione peroxidase (Gex;. rot
Since, HrO, has recently been acknowledged as an important messenger in cellular
regulation, in the present study, the measurement of serum HrO, level was carried out
(within one hour of sampling) and the correlation between HrO, and the major oxidative
stress markers in ESRD patients were assessed. In addition, the levels of creatinine,
cholesterol, LDL, triglyceride, ferritin and albumin in relation to the level of HrO, were also
evaluated.
METHODS
Subjects
The study subjects consisted of 106 ESRD patients (with or without type 2 diabetes mellitus,
DM and/or hypertension) attending the Dialysis Clinic at University Malaya Medical Centre
(UMMC), Kuala Lumpur. The subjects were recruited between the years 2005 and2001 .
The main characteristics of the patients studied are presented in Table l. All the subjects
were on chronic hemodialysis treatment (blood flow: 250m1/min, dialysate flow: 500m1/min,
bicarbonate buffer, substitution volume: 1.8/h), using GambroAK 200 machines. Hepatitis
C patients and those with any other active infections were excluded from the study. The
control subjects (n: 100) mainly comprised healthy blood donors attending the UMMC
with no known clinical/ biochemical abnormality.
This study was approved by the Medical Ethics Committee, UMMC in accordance
with the declaration of Helsinki. Informed consent was obtained from all the participants of
the study.
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Table 1. Demographic and biochemical data of study subjects
Characteristics Control ESRD Patients
lge (mean+ So)
Gender
Male (n)
Female (n)
Ethnicity
Malay (n)
Chinese (n)
Indian (n)
Hemodialysis treatment
Number of sessions per week
Duration of dialysis(years)
Biochemical parameters
Total cholesterol (mmol/L)
HDL(mmol/L)
Triglyceride (mmol/L)
LDL(mmol/L)
Creatinine (umol/L)
Ferritin (ug/L)
Albumin (g/L)
NA (r.68 -4.s3) 2.4 +0.7
100
5 l  +  l ?
36
64
75
l l
l 4
NA (3.6 - 5.2)
NA ( l . l  -  2 .2)
NA (0.4 - 1.5)
NA (62 - 115)
NA.(22 -322)
NA (3s - 50)
106
5 3 + 1 7
63
43
J
t-6
4.33 * 1.4
0.9 + 0.4
2.4 + 1.2
855.8 + 359.7
656.1+339.3
28.5 +9.2
56
3 t
l 9
Notei Data for the biochemical parameters for the ESRD is given as mean + SD. Data not available (NA)
for the control subjects thus, have been presented as the standard normal range.
Sample Preparation
The venous blood samples from the patients were drawn prior to the hemodialysis course.
Blood samples (from patients and healthy volunteers) that were collected into 4 ml EDTA
coated vials and l0 ml plain tube were centrifuged at 2500 xg for l0 min to obtain plasma and
senrm respectively. The plasma was used for the detection ofAdvanced Oxidation Protein
Product, (AOPP) whilst serum was used for the detection of MDA, HrO' and pentosidine.
The MDA and HrO, assays were run irnmediately (within an hour of sampling) to minimise
auto-degradation or autooxidation. The remaining samples were stored at -80"C for the
other assays
Measurement of Hydrogen Peroxide
Serum HrO, concentrations were measured using ferrous ion oxidative xylenol orange
version-2 (FOX-2 assay).ts] The concentration of HrO, in the serum was calculated based
on a calibration curye obtained using H,O, within a concentration range of l0-l00pM.
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Measurement of Pentos idine
Each of the 96-well immunoplate was coated with l00ul of Anti-Pentosidine Ab in 0.05M
carbonate buffer, pH 9.6, covered with aluminum foil and incubated for an hour at room
temperature. The plate was washed thrice with phosphate buffer saline containing 0.05%
TWeen-20 (Buffer A), and incubated with l00ul of serum sample or standard that had been
constituted in buffer A for an hour at room temperature. The plate was washed thrice with
buffer A to remove the unbound Ag (pentosidine). Then the plate was incubated with l00ul of
Conjugate Antibody, Polyclonal Goat Anti-Rabbit Immunoglobulins/HRP (horse radish
peroxidase) for an hour at room temperature. After washing thrice with buffer A, the plate was
further incubated with l00ul of Sodium Citrate Buffer pH5.2 containhg 0.04oh Ortho-
phenylenediamine dihydrochloride and0.09Yo HrO, until an adequate colour developed. The
errz1yme r action was terminated with the addition of l00pl of 0.5M sulphuric acid and the
absorbance was measured at 492nm using a microplate reader. The amount of pentosidine was
quantified based on a calibration curve with a concentration range of l0-2 to l0a nmol/ml.
Measurement of Plasma AOPP
AOPP was determined based on the spectrophotometric method by Witko-Sarsat et al.The
concentrations are expressed as chloramine units (pmol/L).t61
Measurement of Serum MDA
This assay was carried out using thiobarbituric acid method as described by Ratty et al. and
the standard curve was prepared using l,1,3,3-tetraethoxypropane. The concentrations are
expressed as pmol/L.tr)
Biochemical Parameters
Blood creatinine, albumin, total cholesterol, low density lipoprotein (LDL), triglyceride and
fenitin (only ESRD patient samples) were assayed using a Synchron CX7 (Beckman-Coulter
CA, USA) by routine enzymatic methods.
Statistical Analysis
All data were analysed using Statistical Package for Social Science (SPSS l2 for Windows).
Data are expressed as mean+ SD. Statistical significance befween control and ESRD patients
were analysed by analysis of variance (ANOVA) and independent sample /-test. Correlations
between variables were sfudied by Pearson's correlation coeffrcients and differences were
considered signifi cant when p< 0.05.
RESULTS
All ESRD patients (with or without We 2 DM and/or hypertension) had significantly
higher levels of HrO' pentosidine, MDAandAOPPs compared to normal healthy subjects
(Table 2). Interestingly, the serological levels of HrOr, MDA, AOPP and pentosidine in the
ESRD patients were not confounded by age, ethnicity, gender and the presence of co-
morbidities such as type 2 DM or hypertension (results not shown).
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Table 2. Comparison of oxidative indices between ESRD and healthy subjects
ESRD patients Healthy subjects
Pentosidine (nmol/ml) 17.9 * I 1.6** ND
MDA(pmol/L) 1.84 + 0.7** 0.16 + 0.4
AOPP (pmol/L) 448.6 + 168.8** 133.0 + 47.3
H,O, (trM) 29.5 +7.9** 15.5 +1.8
Note:Data is expressed as mean + SD. **p< 0.01 compared to control (Student's t-test).
ND: Not detectable
Table 3. Correlation between HrOr. oxidative indices and
biochemical parameters in ESRD patients
Clinical parameters r
HrO, / Pentosidine
HrOrl MDA
H2Orl AOPP
Triglyceride / HrO,
LDL lH2O2
Creatinine / HrO,
Ferritin / HrO,
Albumin / HrO,
Albumin /AOPP
Albumin / MDA
0.93**
0.80**
0.84**
0.3**
Total Cholesterol / H.O, 0.2*
Albumin / pentosidine -0.40**
0.3**
0.30* +
0.30* *
-0.40**
-0.40**
-0.30**
Note: The analyses were carried out using Pearson's Correlation
Analysis, SPSS version 12.0 for Windows. The data represent
Pearson's Correlation analysis, r values. Significance of
correlation; *p<0.05, **p<0.0 l.
A significant strong positive correlation was present between HrO, and the oxidative
indices (MDA, AOPP and pentosidine) (p<0.01) in the ESRD patients (Table 3). Increasing
levels of HrO, were also positively (weakly) associated with the increasing levels of
higlyceride, ferritin, creatinine, LDL and total cholesterol (Table 3). Anegative correlation
was observed between albumin and the levels of H"O, as well as the oxidative indices in
these patients (Table 3).
DISCUSSION
Serum levels of HrO2 were found to be significantly higher in ESRD patients compared to
the healthy group. This is in agreement with the in vitro study by Tepel et al. which showed
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an increased HrO, production in the lymphocytes of ESRD patients.tsl The net concentration
of HrO, not only depends on the numerous activities within the cell, but also several other
factors such as site and source of HrO, production, the spontaneous and enzymatic
dismutation of HrO, and also the concentration of the protective agents.tr) Although the
half-life of HrO, is short, we have demonstrated that when measured within one hour of
blood sampling, the serum level in ESRD patients is significantly high.
Superoxide dismutase (SOD) levels in ESRD patients have been shown to increase
with the progression of renal insuffrciency.trO'rrl The elevated SOD activity is believed to
increase the conversion rate of Or'radicals to HrOr. Interestingly, several reports have
shown that the activities of HrO, inactivating antioxidant enzymes such as catalase and GPx
are reduced in these patients.t2'tt'tzl Thus, it is possible to speculate that the increased SOD
activity and the decreased catalase and GPx activities result in a net increase in HrO, level,
observed in these ESRD patients.
The levels of oxidative stress biomarkers including pentosidine, AOPP, and MDA were
higher in ESRD subjects compared to normal subjects. This finding is in agreement with our
previous reporttr3l and numerous other reports.[2,6'r2] The imbalance in the activities of
extracellular antioxidant enzymes in the ESRD patients has been suggested to result in the
accumulation of free radical species which in turn could lead to unscheduled oxidation of
susceptible molecules.Ial The reduced levels of detoxifying agents such as reduced
glutathione and catalase may give rise to augmented levels of a wide range of oxidatively
damaged compounds.
This study revealed the existence of strong positive correlations between the levels of
HrO, and the levels of pentosidine, MDA and AOPP indicating that these oxidative stress
biomarkers may be produced via interdependent reactions.tt'61 HrO, is a well known substrate
for the myeloperoxidase enzyme reaction. This reaction yields a very potent oxidising agent,
hypochlorous (HOCI) which has the ability to oxidise lipid, proteoglycans and thiol groups.
HOCI may also react with the endogenous amines to form protein oxidation products such
as 3-chlorotyrosine, dityrosine p'tzl and chloramine which were measured as AOPP in this
study. Uremic state is also in favour of the high level of pentosidine, a marker for advanced
glycation end product (AGE). It is formed by non-enzymatic glycation reactions, which in
tum leads to the formation of shift bases and Amadori products.tts) 11 is noted that Or' can
be generated in the pathway for Amadori product formation. Meanwhile, in the process of
Amadori product degradation, HrO, can be formed via both 1,2- and2,3-enolisation and the
oxidation of enolate anion.tr6l The generation ofOr'byAGE andAOPP could trigger monocyte
NADPH oxidase activation and further lead to the production of H2O2. I'8''31 Schmidt el a/.
showed that H2O2 plays a central role in exacerbating cellular perturbation through AGE-
RAGE interaction via NFrcB activation.tr?l Such evidence and the strong positive correlation
observed in this study support the speculation that AGE and HrO, may be produced
concomitantly.
The present study also showed that HrO, levels were significantly (weakly) correlated
with the level of total cholesterol, LDL and triglyceride in ESRD patients. The elevated
levels oftriglyceride in these patients could increase the risk ofthe lipid peroxidation and
ROS formation.trSl A previous study has reported that the unsaturated double bonds of
fatty acids, which are present in high concentrations in the cell membrane, are susceptible
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to attack by ROS.trel Chronic renal failure patients have been shown to possess younger
and more flexible erythocytes which increases their susceptibility to oxidative damage.tuoJ
The membrane polyunsaturated fatty acids undergo Or- and HrO, mediated lipid peroxidation
process, through several pathways including NADPH-dependent oxidation of microsomal
lipid and xanthine oxidase slstem. trr,zt)
This study also reveals a significant relationship between HrO, and ferritin in the ESRD
patients group. It is noteworthy that ferritin plays an important role in the regulation of
cellular iron homeostasis through the binding of iron regulatory protein and iron responsive
elements which are involved in the production of Or- andH2o2.t23'241 More specifically, the
combined reaction between HrO, (physiological concentrations) and the heme component
of hemoglobin has been shown to induce rapid peroxidation of LDL in vitro,liberating free
iron.t2al The liberation of iron by ferritin is known to stimulate the formation of OH through
Or- and HrO, tz+], which culminates in more macromolecular damage.
Hypoalbunemia is associated with increased mortality in patients with kidney disease.
t26l Interestingly, a negative correlation between serum levels of albumin and HrO, as well
as the oxidative indices was observed in the ESRD patients. Albumin offers its cycteine
sites for the reduction of slower-reacting, diffusible free radical compounds such as HrO,
and HOCI. t2slBrown et al. showed that albumin decreases H.O^ concentration in vitro.t2Tl
Though the relationship between albumin and HrO, levels ii clearly demonstrated in the
present study, the exact role and mechanisms involved require further investigation.
Previously, hydrogen peroxide has been shown to act as a first messenger in its ability
to transmit pro-inflammatory signals from one cell to anothert28l and most disease conditions
have been shown to be in a pro-inflammatory state. The present study implicates a possible
central role played by HrOrin oxidative damages in ESRD patients which ultimately could
manifest in disease complication and mortality.
CONCLUSION
The present study demonstrates the strong, positive relationship between the levels of
serum HrO, and oxidative stress/damage indices namely pentosidine, MDA and AOPPs in
ESRD patients. Serum HrO, levels also showed a weaker but significant positive correlation
with several biochemical parameters and a sigrrificant negative correlation with albumin
which implicates the important role of albumin in reducing the HrO, mediated oxidative
damage. Serum HrO, may also serve as an additional marker that reflects oxidative stress in
ESRD patients.
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